PGR and leiomyoma: Selective progesterone receptor modulators, including ulipristal acetate have shown efficacy in reducing uterine fibroid size and control of bleeding compared to a placebo but there had been no direct comparison between levonorgestrel-releasing intrauterine systems and selective progesterone receptor modulators in women with or without fibroids before this trial.